The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus

Flu's Tricky Tricks After vaccination against influenza A virus, single-point mutations are selected in hemagglutinin (the virus molecule that binds to sialic acid molecules on the surface of host cells) that escape neutralization by polyclonal antibody responses. Hensley et al. (p. 734) have discovered that in mice these mutations increased the virus's avidity for sialic acid. Amino acid substitutions that occur during reiterations of immune escape and avidity modulation can thus drive antigenic variation. This constant evolution of influenza viruses requires us to change vaccine components annually, and, for equine influenza, Park et al. (p. 726) show that as the match between virus and vaccine strains drifts apart with time, the probability of becoming infected and the length of the infectious period increase to the point where outbreaks occur. Nevertheless, even imperfect vaccines may be of benefit to a population because increasing the proportion of vaccinated individuals can supply enough herd immunity to offset a poor antigenic match, especially if used in conjunction with antiviral drugs. For humans, Yang et al. (p. 729, published online 10 September) estimate that the rate of transmission within U.S. households puts influenza A 2009 H1N1 (the current pandemic “swine flu”) in the higher range of transmissibility, compared to past seasonal and pandemic strains. Thus, to achieve mitigation this fall, children should be the first recipients of vaccine, followed by adults—aiming overall for 70% coverage of the population. A detailed picture of the pandemic potential of swine-origin influenza offers guidance for effective mitigation strategies. Pandemic influenza A (H1N1) 2009 (pandemic H1N1) is spreading throughout the planet. It has become the dominant strain in the Southern Hemisphere, where the influenza season has now ended. Here, on the basis of reported case clusters in the United States, we estimated the household secondary attack rate for pandemic H1N1 to be 27.3% [95% confidence interval (CI) from 12.2% to 50.5%]. From a school outbreak, we estimated that a typical schoolchild infects 2.4 (95% CI from 1.8 to 3.2) other children within the school. We estimated the basic reproductive number, R0, to range from 1.3 to 1.7 and the generation interval to range from 2.6 to 3.2 days. We used a simulation model to evaluate the effectiveness of vaccination strategies in the United States for fall 2009. If a vaccine were available soon enough, vaccination of children, followed by adults, reaching 70% overall coverage, in addition to high-risk and essential workforce groups, could mitigate a severe epidemic.

[1]  F. Dunn,et al.  Epidemiologic studies of Asian influenza in a Louisiana parish. , 1959, American journal of hygiene.

[2]  I. Longini,et al.  An optimization model for influenza A epidemics , 1978 .

[3]  I. Longini,et al.  Household and community transmission parameters from final distributions of infections in households. , 1982, Biometrics.

[4]  R. Couch,et al.  The influenza herald wave. , 1982, American journal of epidemiology.

[5]  I M Longini,et al.  Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.

[6]  L. A. Rvachev,et al.  A mathematical model for the global spread of influenza , 1985 .

[7]  J. H. Ellis,et al.  Modeling the Spread of Annual Influenza Epidemics in the U.S.: The Potential Role of Air Travel , 2004, Health care management science.

[8]  J. Robins,et al.  Transmissibility of 1918 pandemic influenza , 2004, Nature.

[9]  A. Nizam,et al.  Containing Pandemic Influenza at the Source , 2005, Science.

[10]  M. Elizabeth Halloran,et al.  Community Studies for Vaccinating Schoolchildren Against Influenza , 2006, Science.

[11]  C. Macken,et al.  Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Mark A. Miller,et al.  Seasonal influenza in the United States, France, and Australia: transmission and prospects for control , 2007, Epidemiology and Infection.

[13]  Gerardo Chowell,et al.  Estimating the reproduction number from the initial phase of the Spanish flu pandemic waves in Geneva, Switzerland. , 2007, Mathematical biosciences and engineering : MBE.

[14]  Yang Yang,et al.  A data-augmentation method for infectious disease incidence data from close contact groups , 2007, Comput. Stat. Data Anal..

[15]  M. Elizabeth Halloran,et al.  Detecting Human-to-Human Transmission of Avian Influenza A (H5N1) , 2007, Emerging Infectious Diseases.

[16]  C. Macken,et al.  Modeling targeted layered containment of an influenza pandemic in the United States , 2008, Proceedings of the National Academy of Sciences.

[17]  M. Halloran,et al.  Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data , 2008, American journal of epidemiology.

[18]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[19]  Case Reports Update: swine influenza A (H1N1) infections--California and Texas, April 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[20]  A. Nizam,et al.  Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  A. Usa,et al.  Update: swine influenza A (H1N1) infections--California and Texas, April 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[22]  M. Halloran,et al.  Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States , 2009, American journal of epidemiology.

[23]  Robert Schechter,et al.  Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[24]  Simon Cauchemez,et al.  Assessing the severity of the novel influenza A/H1N1 pandemic , 2009, BMJ : British Medical Journal.

[25]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.